| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.33 | 0.05 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.33 | 0.007 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.27 | 1e-14 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.26 | 2e-14 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.26 | 2e-06 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.24 | 0.1 |